SS
ADMA icon

Simplicity Solutions’s ADMA Biologics ADMA Stock Holding History

Simplicity Solutions’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$46.8K Sell
10,355
-103
-1% -$381 ﹤0.01% 1045
2023
Q3 		$37.4K Sell
10,458
-564
-5% -$2.17K ﹤0.01% 968
2023
Q2 		$40.7K Sell
11,022
-340
-3% -$1.26K ﹤0.01% 1033
2023
Q1 		$37.6K Buy
+11,362
New +$39.3K ﹤0.01% 1105

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Simplicity Solutions's ADMA Position: Q4 2023 in Review

Simplicity Solutions reduced its ADMA Biologics (ADMA) stake by 0.98% in Q4 2023, selling an estimated $381 and leaving 10,355 shares worth $46.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1045.

Simplicity Solutions first reported a position in ADMA in Q1 2023 and has held it in 4 quarters since. 184 funds tracked by Wall St. Rank hold ADMA as of Q4 2023.

  • Simplicity Solutions held 10,355 shares of ADMA Biologics worth $46.8K as of Q4 2023.
  • Simplicity Solutions sold 103 ADMA Biologics shares in Q4 2023, an estimated $381.
  • ADMA Biologics made up ﹤0.01% of Simplicity Solutions's portfolio in Q4 2023, its #1045 holding.
  • Simplicity Solutions first reported a position in ADMA Biologics in Q1 2023 and has held it in 4 quarters since.
  • 184 funds tracked by Wall St. Rank held ADMA Biologics as of Q4 2023.

Based on Simplicity Solutions's 13F filing for Q4 2023, filed 29 Jan 2024.